Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus.

Ziarek JJ, Veldkamp CT, Zhang F, Murray NJ, Kartz GA, Liang X, Su J, Baker JE, Linhardt RJ, Volkman BF.

J Biol Chem. 2013 Jan 4;288(1):737-46. doi: 10.1074/jbc.M112.394064. Epub 2012 Nov 12.

2.

Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin.

Murphy JW, Cho Y, Sachpatzidis A, Fan C, Hodsdon ME, Lolis E.

J Biol Chem. 2007 Mar 30;282(13):10018-27. Epub 2007 Jan 29.

3.

Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis.

Fermas S, Gonnet F, Sutton A, Charnaux N, Mulloy B, Du Y, Baleux F, Daniel R.

Glycobiology. 2008 Dec;18(12):1054-64. doi: 10.1093/glycob/cwn088. Epub 2008 Sep 16.

PMID:
18796646
4.

Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions.

Joseph PR, Mosier PD, Desai UR, Rajarathnam K.

Biochem J. 2015 Nov 15;472(1):121-33. doi: 10.1042/BJ20150059. Epub 2015 Sep 14.

5.

Characterization of the stromal cell-derived factor-1alpha-heparin complex.

Sadir R, Baleux F, Grosdidier A, Imberty A, Lortat-Jacob H.

J Biol Chem. 2001 Mar 16;276(11):8288-96. Epub 2000 Nov 21.

6.

The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4.

Laguri C, Sadir R, Rueda P, Baleux F, Gans P, Arenzana-Seisdedos F, Lortat-Jacob H.

PLoS One. 2007 Oct 31;2(10):e1110.

7.

Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12.

Veldkamp CT, Ziarek JJ, Su J, Basnet H, Lennertz R, Weiner JJ, Peterson FC, Baker JE, Volkman BF.

Protein Sci. 2009 Jul;18(7):1359-69. doi: 10.1002/pro.167.

8.

Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.

Ziarek JJ, Getschman AE, Butler SJ, Taleski D, Stephens B, Kufareva I, Handel TM, Payne RJ, Volkman BF.

ACS Chem Biol. 2013 Sep 20;8(9):1955-63. doi: 10.1021/cb400274z. Epub 2013 Jun 26.

9.

Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo.

Lau EK, Paavola CD, Johnson Z, Gaudry JP, Geretti E, Borlat F, Kungl AJ, Proudfoot AE, Handel TM.

J Biol Chem. 2004 May 21;279(21):22294-305. Epub 2004 Mar 18.

10.

Stoichiometry and geometry of the CXC chemokine receptor 4 complex with CXC ligand 12: molecular modeling and experimental validation.

Kufareva I, Stephens BS, Holden LG, Qin L, Zhao C, Kawamura T, Abagyan R, Handel TM.

Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5363-72. doi: 10.1073/pnas.1417037111. Epub 2014 Dec 2.

11.

Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo.

Mellor P, Harvey JR, Murphy KJ, Pye D, O'Boyle G, Lennard TW, Kirby JA, Ali S.

Br J Cancer. 2007 Sep 17;97(6):761-8. Epub 2007 Aug 28.

12.

Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry.

Yu Y, Sweeney MD, Saad OM, Crown SE, Hsu AR, Handel TM, Leary JA.

J Biol Chem. 2005 Sep 16;280(37):32200-8. Epub 2005 Jul 20. Erratum in: J Biol Chem. 2005 Dec 9;280(49):41124. Hsu, Andro R [added].

13.

Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences.

Cutolo P, Basdevant N, Bernadat G, Bachelerie F, Ha-Duong T.

J Biomol Struct Dyn. 2017 Feb;35(2):399-412. doi: 10.1080/07391102.2016.1145142. Epub 2016 Jul 11.

PMID:
26813575
14.

The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.

Dyer DP, Salanga CL, Volkman BF, Kawamura T, Handel TM.

Glycobiology. 2016 Mar;26(3):312-26. doi: 10.1093/glycob/cwv100. Epub 2015 Nov 17.

15.

Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites.

Goger B, Halden Y, Rek A, Mösl R, Pye D, Gallagher J, Kungl AJ.

Biochemistry. 2002 Feb 5;41(5):1640-6.

PMID:
11814358
16.

Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction.

Saini V, Marchese A, Tang WJ, Majetschak M.

J Biol Chem. 2011 Dec 23;286(51):44145-52. doi: 10.1074/jbc.M111.298505. Epub 2011 Oct 28.

17.

Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).

Veldkamp CT, Seibert C, Peterson FC, Sakmar TP, Volkman BF.

J Mol Biol. 2006 Jun 23;359(5):1400-9. Epub 2006 May 11.

18.

Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12.

Veldkamp CT, Seibert C, Peterson FC, De la Cruz NB, Haugner JC 3rd, Basnet H, Sakmar TP, Volkman BF.

Sci Signal. 2008 Sep 16;1(37):ra4. doi: 10.1126/scisignal.1160755.

19.
20.

Technical advance: Surface plasmon resonance-based analysis of CXCL12 binding using immobilized lentiviral particles.

Vega B, Muñoz LM, Holgado BL, Lucas P, Rodríguez-Frade JM, Calle A, Rodríguez-Fernández JL, Lechuga LM, Rodríguez JF, Gutiérrez-Gallego R, Mellado M.

J Leukoc Biol. 2011 Aug;90(2):399-408. doi: 10.1189/jlb.1010565. Epub 2011 May 18.

PMID:
21593136

Supplemental Content

Support Center